Stable angina pectoris: population trends, diagnostics, secondary prevention, and antianginal therapy
Aim. To assess compliance with international clinical guidelines on coronary heart disease (CHD) secondary prevention, as well as on stable angina pectoris diagnostics and treatment, in Russian clinical practice settings. Material and methods . Among 5000 randomly selected out-patients visiting Mosc...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2006-02-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1112 |
| _version_ | 1827064116421853184 |
|---|---|
| author | R. G. Oganov V. K. Lepakhin S. B. Fitilev A. M. Levin I. I. Shkrebneva Yu. Yu. Titarova M. K. Doronkina |
| author_facet | R. G. Oganov V. K. Lepakhin S. B. Fitilev A. M. Levin I. I. Shkrebneva Yu. Yu. Titarova M. K. Doronkina |
| author_sort | R. G. Oganov |
| collection | DOAJ |
| description | Aim. To assess compliance with international clinical guidelines on coronary heart disease (CHD) secondary prevention, as well as on stable angina pectoris diagnostics and treatment, in Russian clinical practice settings. Material and methods . Among 5000 randomly selected out-patients visiting Moscow City Cardiology Dispanser (MCCD) in 2001, 1840 patients with stable angina diagnosis were identified. Out-patient medical documents were studied, and information on CHD risk factor (RF) registration, clinical diagnosis, clinical and laboratory tests, therapy (agents and their doses), associated diseases and their treatment, was analyzed. Results. Moscow doctors, in spite of existing international and national clinical guidelines, do not use objective diagnostic tests and rely on subjective complaints, while assessing disease severity and determining management tactics, in every second patient (49.2%). The doctors inadequately address RF in stable angina patients, fail to modify RF effectively, and do not attain RF target levels. The principal problems of pharmacotherapy are inadequately low use of statins in CHD secondary prevention (1.8% at out-patient clinics; 6.4% Ц at MCCD), as well as use of minimal effective doses for most antianginal agents. Coronarography, coronary angioplasty, and bypass surgery rates are substantially lower than those in Eastern European countries. Conclusion. The recommendations of national and international guidelines on CHD secondary prevention, stable angina diagnostics and treatment, are still fulfilled inadequately. |
| first_indexed | 2024-04-10T03:40:56Z |
| format | Article |
| id | doaj.art-c79ab92816784547a24684402a059911 |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2025-03-19T22:42:02Z |
| publishDate | 2006-02-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-c79ab92816784547a24684402a0599112024-10-17T12:21:23Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252006-02-01514954824Stable angina pectoris: population trends, diagnostics, secondary prevention, and antianginal therapyR. G. Oganov0V. K. Lepakhin1S. B. Fitilev2A. M. Levin3I. I. Shkrebneva4Yu. Yu. Titarova5M. K. Doronkina6State Research Center for Preventive Medicine, Russian Federal Agency of Health and Social DevelopmentRussian University of PeopleТs Friendship. MoscowRussian University of PeopleТs Friendship. MoscowRussian University of PeopleТs Friendship. MoscowRussian University of PeopleТs Friendship. MoscowRussian University of PeopleТs Friendship. MoscowRussian University of PeopleТs Friendship. MoscowAim. To assess compliance with international clinical guidelines on coronary heart disease (CHD) secondary prevention, as well as on stable angina pectoris diagnostics and treatment, in Russian clinical practice settings. Material and methods . Among 5000 randomly selected out-patients visiting Moscow City Cardiology Dispanser (MCCD) in 2001, 1840 patients with stable angina diagnosis were identified. Out-patient medical documents were studied, and information on CHD risk factor (RF) registration, clinical diagnosis, clinical and laboratory tests, therapy (agents and their doses), associated diseases and their treatment, was analyzed. Results. Moscow doctors, in spite of existing international and national clinical guidelines, do not use objective diagnostic tests and rely on subjective complaints, while assessing disease severity and determining management tactics, in every second patient (49.2%). The doctors inadequately address RF in stable angina patients, fail to modify RF effectively, and do not attain RF target levels. The principal problems of pharmacotherapy are inadequately low use of statins in CHD secondary prevention (1.8% at out-patient clinics; 6.4% Ц at MCCD), as well as use of minimal effective doses for most antianginal agents. Coronarography, coronary angioplasty, and bypass surgery rates are substantially lower than those in Eastern European countries. Conclusion. The recommendations of national and international guidelines on CHD secondary prevention, stable angina diagnostics and treatment, are still fulfilled inadequately.https://cardiovascular.elpub.ru/jour/article/view/1112pharmaco-epidemiologic studyanginaclinical trials |
| spellingShingle | R. G. Oganov V. K. Lepakhin S. B. Fitilev A. M. Levin I. I. Shkrebneva Yu. Yu. Titarova M. K. Doronkina Stable angina pectoris: population trends, diagnostics, secondary prevention, and antianginal therapy Кардиоваскулярная терапия и профилактика pharmaco-epidemiologic study angina clinical trials |
| title | Stable angina pectoris: population trends, diagnostics, secondary prevention, and antianginal therapy |
| title_full | Stable angina pectoris: population trends, diagnostics, secondary prevention, and antianginal therapy |
| title_fullStr | Stable angina pectoris: population trends, diagnostics, secondary prevention, and antianginal therapy |
| title_full_unstemmed | Stable angina pectoris: population trends, diagnostics, secondary prevention, and antianginal therapy |
| title_short | Stable angina pectoris: population trends, diagnostics, secondary prevention, and antianginal therapy |
| title_sort | stable angina pectoris population trends diagnostics secondary prevention and antianginal therapy |
| topic | pharmaco-epidemiologic study angina clinical trials |
| url | https://cardiovascular.elpub.ru/jour/article/view/1112 |
| work_keys_str_mv | AT rgoganov stableanginapectorispopulationtrendsdiagnosticssecondarypreventionandantianginaltherapy AT vklepakhin stableanginapectorispopulationtrendsdiagnosticssecondarypreventionandantianginaltherapy AT sbfitilev stableanginapectorispopulationtrendsdiagnosticssecondarypreventionandantianginaltherapy AT amlevin stableanginapectorispopulationtrendsdiagnosticssecondarypreventionandantianginaltherapy AT iishkrebneva stableanginapectorispopulationtrendsdiagnosticssecondarypreventionandantianginaltherapy AT yuyutitarova stableanginapectorispopulationtrendsdiagnosticssecondarypreventionandantianginaltherapy AT mkdoronkina stableanginapectorispopulationtrendsdiagnosticssecondarypreventionandantianginaltherapy |